Key Highlights
- 11.62% is the indicated pre-market gain for SciSparc Ltd. (NASDAQ:SPRC) on November 18, 2026, lifting the price to USD 0.368 from a calculated prior close of USD 0.3297, a calculated USD 0.0383 move.
- 1-for-9 was the reverse share split effective at the market open on March 4, 2026, which cut outstanding ordinary shares from about 5.1 million to about 565,500 after the stock fell 12.87% to USD 0.48.
- 4.4 million USD was cash in the first half of 2026, up from USD 1.5 million at year-end 2025, against a negative Working Capital of USD 1.4 million and an accumulated Deficit of USD 92.5 million.
- 6.1 million USD was the first-half 2026 net loss on Revenue of USD 284,000, down 38%, with an operating loss of USD 4.9 million versus USD 6.0 million a year earlier.
What Moved SciSparc Ltd. (NASDAQ:SPRC) in Pre-Market Trading on November 18, 2026 (+USD 0.0383, +11.62%)
The indicated pre-market price for SciSparc Ltd. (NASDAQ:SPRC) is USD 0.368 on November 18, 2026, a pre-market move of +11.62%. The calculated prior close is USD 0.3297 (USD 0.368 divided by 1.1162), and the calculated USD move is +USD 0.0383. The price is below USD 1.00. A corroborated market Capitalization and pre-market Volume were not found, and published market data show a 52-week price change of -96.43%.
The Rationale: No Catalyst Identified Amid Dilution Pressure for SciSparc Ltd. (NASDAQ:SPRC)
No catalyst for the November 18, 2026 move was identified in published coverage. As background, shareholders approved the reverse split at the June 2025 annual general meeting, and shares kept trading on the Nasdaq Capital Market under SPRC. The company develops cannabinoid candidates SCI-110 and SCI-210, runs an E-commerce segment, and is adding CliniQ, a quantum simulation subsidiary. Its NeuroThera Subsidiary raised USD 3.8 million. As general context, low-priced small-cap shares with thin float can swing sharply on small order flow or sympathy moves.
Valuation, Liquidity and Risks for SciSparc Ltd. (NASDAQ:SPRC)
Filings carry a going-concern warning citing substantial doubt about the group's ability to continue. Published market data show Debt of USD 2.68 million and a trailing twelve-month net loss of USD 8.22 million on revenue of USD 679,000. Convertible promissory notes were sold at a 90% purchase price, which adds dilution risk, and the share count has risen sharply since the reverse split. A corroborated market capitalization is not available, but the share price and loss history point to a nano-cap or micro-cap profile with elevated risk of delisting notices, further reverse splits and dilution.
Where Things Stand
SciSparc Ltd. (NASDAQ:SPRC) is indicated up 11.62% in pre-market trading on November 18, 2026, at USD 0.368, a calculated USD 0.0383 above a prior close of USD 0.3297. No catalyst was identified in published coverage. The first half of 2026 showed revenue of USD 284,000, a net loss of USD 6.1 million, cash of USD 4.4 million and negative working capital of USD 1.4 million, after a 1-for-9 reverse split in March 2026. Going-concern language, dilution from convertible notes and low-price Volatility are key risks, pre-market moves can reverse at the 9:30 a.m. ET open, and this is not Investment advice.


_11_18_2026_12_50_29_022597.jpg)



Please wait processing your request...